2022
DOI: 10.1080/14786419.2022.2142221
|View full text |Cite
|
Sign up to set email alerts
|

Alkylamides from Acmella oleracea: antinociceptive effect and molecular docking with cannabinoid and TRPV1 receptors

Abstract: Alkylamides are secondary metabolites in Acmella oleracea and display wide applications in treating several diseases. Since alkylamides can inhibit pain, this work aims to evaluate the antinociceptive profile of A. Oleracea methanolic extracts usingin vivo and in silico assays. The extracts inhibited the neurogenic and inflammatory phases of the formalin test, ratifying the antinociceptive effect of alkylamides.Furthermore, the results from molecular docking demonstrated the interaction of A. oleracea alkylami… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

2
5
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 8 publications
(7 citation statements)
references
References 35 publications
2
5
0
Order By: Relevance
“…These results suggest that one of the mechanisms underlying the antihypertensive action of this alkamide implies activation of CB1 cannabinoid receptors. A recent study demonstrated, through a molecular docking analysis, that the mechanism of action responsible for the antinociceptive effect of AF could involve CB1 cannabinoid receptors [32], which supports the results we obtained in the present work.…”
Section: Discussionsupporting
confidence: 93%
See 1 more Smart Citation
“…These results suggest that one of the mechanisms underlying the antihypertensive action of this alkamide implies activation of CB1 cannabinoid receptors. A recent study demonstrated, through a molecular docking analysis, that the mechanism of action responsible for the antinociceptive effect of AF could involve CB1 cannabinoid receptors [32], which supports the results we obtained in the present work.…”
Section: Discussionsupporting
confidence: 93%
“…These results suggest that one of the mechanisms underlying the antihypertensive action of this alkamide implies activation of CB1 cannabinoid receptors. A recent study demonstrated, through a molecular docking analysis, that the mechanism of action responsible for the antinociceptive effect of affinin could involve CB1 receptors [32], which supports the results we obtained in the present work. Lake et al (1997) showed that rimonabant blocked the hypotension induced by anandamide in conscious SHR, suggesting involvement of CB1 cannabinoid receptors in the blood pressure-lowering effect of this endocannabinoid [33].…”
Section: Accepted Manuscriptsupporting
confidence: 93%
“…Investigations suggest that the analgesic and antinociceptive effects of spilanthol involve the activation of opioidergic, serotoninergic, and GABAergic systems, with an increased release of GABA mediated by the alkylamide [7,8]. In vivo studies prove the antinociceptive effect in several different mouse pain models [9][10][11]. Additional in silico molecular docking evaluations show that alkylamides from A. oleracea, including spilanthol, can interact with CB1, CB2, and TRPV1 receptors [11].…”
Section: Introductionmentioning
confidence: 97%
“…Different extracts of A. oleracea have been reported to hold numerous important biological activities, including a local anesthetic property, which is the main reason why A. oleracea has been used since ancient times to relieve toothache. In addition, anti-inflammatory, analgesic, cytotoxic, antioxidant, antimicrobial, anthelmintic, antiwrinkling, aphrodisiac, and insecticidal/acaricidal properties are reported [1][2][3][4][5][6][7].…”
Section: Introductionmentioning
confidence: 99%